KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $19,000 | +35.7% | 5,600 | +41.7% | 0.00% | – |
| Q2 2018 | $14,000 | -65.9% | 3,953 | -44.0% | 0.00% | -100.0% |
| Q4 2016 | $41,000 | -73.2% | 7,057 | -75.6% | 0.00% | -80.0% |
| Q3 2016 | $153,000 | +12.5% | 28,898 | +40.6% | 0.01% | +11.1% |
| Q2 2016 | $136,000 | +248.7% | 20,554 | +144.7% | 0.01% | +200.0% |
| Q1 2016 | $39,000 | +18.2% | 8,398 | +27.3% | 0.00% | 0.0% |
| Q4 2015 | $33,000 | +83.3% | 6,598 | +249.5% | 0.00% | +50.0% |
| Q2 2015 | $18,000 | +157.1% | 1,888 | +213.1% | 0.00% | +100.0% |
| Q1 2015 | $7,000 | – | 603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
| HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
| Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
| Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
| SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
| Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
| DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
| NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |